MAP2K7 and meningioma: IGFs, particularly IGF-1, bind to their receptors on meningioma cells, activating intracellular signaling cascades such as the PI3K/Akt and Ras/Raf/MEK/ERK pathways, which promote cellular proliferation and survival (39, 40).